The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies

Background: Electrochemiluminescence (ECL) assays have shown promise for enhancing the prediction of type 1 diabetes (T1D) with autoantibodies. We thus studied relatives of T1D patients to determine whether ECL assays can be used to refine risk assessments for T1D among individuals either positive f...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Technol Ther
Main Authors: Sosenko, Jay M., Yu, Liping, Skyler, Jay S., Krischer, Jeffrey P., Gottlieb, Peter A., Boulware, David, Miao, Dongmei, Palmer, Jerry P., Steck, Andrea K.
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc. 2017
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5359659/
https://ncbi.nlm.nih.gov/pubmed/28177779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2016.0243
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares